Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Japan
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Fukuoka, Kawasaki, Miyagi, Tokyo
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - Phase 1/2Taking peopleSafety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder
- Where
- Fukuoka
- Age
- 18 years and over
- People
- 7
- Run by
- Kyushu University
See details and how to joinNCT07738952